Results 331 to 340 of about 8,234,457 (404)

Enhancing pharmacovigilance for robust drug safety monitoring: addressing underreporting and collaborative solutions. [PDF]

Ther Adv Drug Saf
Sree Sudha TY, Meena B, Pareek S, Singh H.   +3 more
europepmc   +1 more source

Letter to the Editor: Discussion on the suicide risk of CCB drugs: based on real-world drug safety surveillance. [PDF]

Psychol Med
Luo D, Wu J, Liu B.
europepmc   +1 more source

Sequential Epidemiological Analyses of Real-World Data: A Tool for Prospective Drug Safety Surveillance from the Rofecoxib Example. [PDF]

Drug Saf
Abbasi SH, Lund LC, Hallas J, Pottegård A.   +3 more
europepmc   +1 more source

Inhaled pulmonary vasodilators for persistent pulmonary hypertension of the newborn: safety issues relating to drug administration and delivery devices

, 2016
N Cosa, E Costa
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

A drug safety evaluation of risankizumab for psoriasis

Expert Opinion on Drug Safety, 2020
Introduction: Risankizumab is a fully human monoclonal antibody that selectively targets interleukin (IL)-23A, interfering with the IL-23/17 axis that plays a crucial role in keratinocyte proliferation. In 2019, risankizumab was approved globally for the
Yi-Wei Huang, T. Tsai
semanticscholar   +1 more source

The utilization and challenges of Japan's MID‐NET® medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies

Pharmacoepidemiology and Drug Safety, 2019
To examine the potential role of Medical Information Database Network (MID‐NET®), a newly established Japanese medical information database network, in postmarketing drug safety assessments through the characterization of its advantages and limitations ...
Kaori Yamada, Maori Itoh, Yoshiaki Fujimura, M. Kimura, K. Murata, N. Nakashima, M. Nakayama, K. Ohe, T. Orii, Eizaburo Sueoka, Takahiro Suzuki, H. Yokoi, Chieko Ishiguro, Y. Uyama   +13 more
semanticscholar   +1 more source

Drug safety, drug quality, drug analysis

Journal of Pharmaceutical and Biomedical Analysis, 2008
Controlling and minimizing the side effects of drugs are the key issues in assuring the safety of drug therapy. Since side effects are inherent properties of the drug material, these cannot be influenced by drug analysts. At the same time drug analysts play a predominant role in assuring the quality of bulk drug materials and drug formulations and this
openaire   +2 more sources

Pharmaceutical drug safety

2010
The occurrence of sometimes life-threatening adverse drug reactions (ADRs) jeopardizes patients’ health during drug treatment and additionally imposes an increased financial burden on the healthcare system. The withdrawal of already marketed drugs because of ADRs furthermore erodes public confidence in the way drugs are approved.
openaire   +1 more source

Advances in Drug Safety

Current Pharmaceutical Design, 2012
The operating room offers a unique setting where anesthetics, preoperative medications, patient comorbidities, and surgery all merge. Anesthesiologists are responsible for combining these concerns into a dependable and safe approach. From formulation to administration, enhancements in nearly every aspect of a given drug have improved the ability of ...
J Adam, Cartwright, Steven, Aniskevich, Christopher B, Robards, Harish, Ramakrishna, Sorin J, Brull, Steven R, Clendenen   +5 more
openaire   +2 more sources

Safety of obesity drugs

Expert Opinion on Drug Safety, 2005
The safety of obesity drugs has historically been poor. This and the stigmatisation of obesity in society ensured that a higher standard of safety for obesity drugs must be met. The authors review the safety disasters of obesity drugs that were withdrawn.
Frank L, Greenway, Mary K, Caruso
openaire   +2 more sources